ArticleCancer science2012

Epidermal growth factor receptor R521K polymorphism shows favorable outcomes in KRAS wild-type colorectal cancer patients treated with cetuximab-based chemotherapy.

Yao-Yu Hsieh et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.